Study of Subclinical Viral Infection

Conditions:Renal Impairment / Chronic Kidney Disease, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Nephrology / Urology
Age Range:1 - 25
Start Date:October 2011
End Date:October 2016
Contact:Jodi Smith, MD

Use our guide to learn which trials are right for you!

Subclinical Viral Infection and Renal Allograft Injury

Chronic allograft injury is the leading cause of graft loss in renal transplantation. The
shortage of available kidneys for transplantation has reached crisis levels with increasing
numbers of waiting list mortalities. Strategies to prolong graft survival are urgently
needed. The pediatric and young adult transplant population is one in which repeat
transplantation is inevitable and therefore, this group is one who will especially benefit
from intervention to prolong graft survival. The hypothesis of this proposal is that
subclinical viral infection is a modifiable risk factor in the pathogenesis of chronic
allograft injury. The young age of the proposed study population is an ideal one to evaluate
this objective due to the high prevalence of seronegative recipients. The studies outlined
will determine the temporal relationship betWeween subclinical viremia, renal allograft
infection and allograft injury. This will be the first prospective study in renal transplant
recipients to systematically monitor subclinical viral infection both in peripheral blood
and in the renal allograft with concurrent quantitative measures of renal function,
allograft fibrosis, and innate immune activation. The investigators have chosen these 3
outcomes because they evaluate a spectrum of renal allograft injury and represent different
stages - from early to late - in the pathophysiology that leads to renal allograft
dysfunction. In addition, the role of virus specific T cell immune responses in the control
of subclinical viral infection and associated allograft injury will be determined. These
data are critical as they will provide insights into the pathogenesis of injury and will
guide development of interventions strategies. Importantly, the current treatment strategies
for viral disease do not prevent subclinical viral infection. Thus, the results of this
study may identify that prevention, prophylaxis and/or treatment of subclinical viral
replication as a long term strategy to prevent chronic allograft injury and prolong graft

Inclusion Criteria:

- Subject and/or parent guardian must be able to understand and provide informed
consent or assent

- Male or Female, Seattle Children's Hospital participants must be 1-<21 yrs and
University of Washington Medical Center participants 18-25yrs.

- Diagnosed with End Stage Renal Disease (ESRD)

Exclusion Criteria:

- Inability or unwillingness of subject and/or parent guardian to provide informed

- Pregnancy
We found this trial at
4800 Sand Point Way NE
Seattle, Washington 98105
(206) 987-2000
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
Seattle, WA
Click here to add this to my saved trials